×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)

B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)

货号:CL-0575

规格:1×10⁶cells/T25培养瓶

价格: ¥1800

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
  • B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确) ¥1800
B-CPAP [BC-PAP; BCPAP]细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥2150¥2250

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 B-CPAP [BC-PAP; BCPAP] (人甲状腺乳头状癌细胞) (STR鉴定正确)
别称 BC-PAP; BCPAP
种属
生长特性 贴壁细胞
细胞形态 圆形/长梭形
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:5
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 Established from the tumor tissue of a 76-year-old woman with metastasizing papillary thyroid carcinoma in 1992
年龄(性别) 女性;76岁
组织来源 甲状腺组织
细胞类型 肿瘤细胞
肿瘤类型 其它肿瘤细胞
生物安全等级 BSL-1
倍增时间 ~30 hours
保藏机构 DSMZ; ACC-273
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 13
    D2S1338 18
    D3S1358 16,17
    D5S818 10,11
    D7S820 10
    D8S1179 12,13
    D13S317 12
    D16S539 11,12
    D18S51 13,17
    D19S433 13.2,15
    D21S11 30,31.2
    FGA 20,23
    PentaD 10,11
    PentaE 5,12
    TH01 6,9.3
    TPOX 8,11
    vWA 14,17
    D6S1043 12,19
    D12S391 18,23
    D2S441 11
  • STR鉴定图
参考文献
文献列表
  • Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission (2024-02-09)

    作者:Ya-Wen Guo:1.Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China. ; 2.Department of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310014, China. ; 3.Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, 310014, China. ; 4.Clinical Research Center for Cancer of Zhejiang Province, 310014, Hangzhou, Zhejiang, China. ; Lei Zhu:1.Department of Thyroid Surgery, The Fifth Hospital Affiliated to Wenzhou Medical University, Lishui Central Hospital, Lishui City, Zhejiang, 323000, China. ; Yan-Ting Duan:1.Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China. ; 2.Key Laboratory of Endocrine Gland Diseases

    期刊:Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission

    DOI:10.1038/s41419-024-06511-1

    影响因子 :9.0

    引用产品: Nthy-ori 3-1 细胞 ,  TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  IHH-4 细胞

  • Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis (2024-01-09)

    作者:Shuhui Wu:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Jingjing Zhu:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Tingting Jiang:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Ting Cui:1.Department of Thyroid Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Rep

    期刊:Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis

    DOI:10.1186/s13148-023-01622-6

    影响因子 :5.7

    引用产品: B-CPAP [BC-PAP; BCPAP] 细胞 ,  TPC-1 细胞 ,  Nthy-ori 3-1 细胞

  • AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling (2024-01-18)

    作者:Gaoda Ju:1.Department of Medical Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, Beijing 100730, China; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing 100730, China. ; Tao Xing:1.Department of Medical Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China. ; Miaomiao Xu:1.Shanghai Clinical Research and Trial Center, Shanghai 201210, China. ; Xin Zhang:1.Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science

    期刊:AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling

    DOI:10.1016/j.neo.2024.100972

    影响因子 :4.8

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞

  • DNMT1/DNMT3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression (2024-01-17)

    作者:Zanbin Li:1.Department of Thyroid and Hernia Surgery, First Affiliated Hospital of Gannan Medical College, No. 128, Jinling West Road, Ganzhou, 341000, Jiangxi, People's Republic of China. ; Yong Ying:1.Department of Thyroid and Hernia Surgery, First Affiliated Hospital of Gannan Medical College, No. 128, Jinling West Road, Ganzhou, 341000, Jiangxi, People's Republic of China. ; Xiangtai Zeng:1.Department of Thyroid and Hernia Surgery, First Affiliated Hospital of Gannan Medical College, No. 128, Jinling West Road, Ganzhou, 341000, Jiangxi, People's Republic of China. ; Jiafeng Liu:1.Department of Thyroid and Hernia Surgery, First Affiliated Hospital of Gannan Medical College, No. 128, Jinling West Road, Ganzhou, 341000, Jiangxi, People's Republic of China. ; Yang Xie:1.Department of Thyroid and Hernia Surgery, First Affiliated Hospital of Gannan Medical College, No. 128, Jinling West Road, Ganzhou, 341000, Jiangxi, People's Republic of China. ; Zefu Deng:1.Department of Thyroid a

    期刊:DNMT1/DNMT3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression

    DOI:10.1007/s10142-024-01293-3

    影响因子 :2.9

    引用产品: B-CPAP [BC-PAP; BCPAP] 细胞 ,  8305C 细胞 ,  BHT101 细胞 ,  CAL-62 细胞

  • RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex (2023-02-21)

    作者:Debin Xu:1.Department of Thyroid Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Jichun Yu:1.Department of Thyroid Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Yuting Yang:1.Department of Intensive Care Unit, First Affiliated Hospital of Nanchang University, No. 17, Yongwai Main Street, Nanchang, 330006, China. ; Yunyan Du:1.School of Pharmacy, Nanchang University, No. 471, Bayi Road, Nanchang, 330006, China. ; Hongcheng Lu:1.Department of General Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Shouhua Zhang:1.Department of General Surgery, Affiliated Children's Hospital of Nanchang University, No. 122, Yangming Road, Nanchang, 330006, China. ; Qian Feng:1.Department of General Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Yi Yu:1.Department of Urolo

    期刊:RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex

    DOI:10.1186/s13578-023-00987-8

    影响因子 :7.5

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  KTC-1 细胞 ,  C643 细胞 ,  CAL-62 细胞 ,  8305C 细胞 ,  KMH-2 细胞 ,  KHM-5M 细胞 ,  BHT101 细胞

  • FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma (2023-03-22)

    作者:Yawei He:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ; Wanjing Chen:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ; Liang Yu:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ; Yanwei Liu:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ; Yunsheng Cheng:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ; Xianghua Li:1.Department of Molecular Pathology, Hefei Da'an Medical Laboratory Co., Ltd, Hefei, China. ; Gang Yu:1.Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. ;

    期刊:FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma

    DOI:10.1111/1440-1681.13773

    影响因子 :2.9

    引用产品: B-CPAP [BC-PAP; BCPAP] 细胞 ,  BHT101 细胞 ,  293T [HEK-293T] 细胞

  • New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network (2023-12-27)

    作者:Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China. ; Lan Chen:1.The Second Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. ; Ximing Qu:1.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China. ; Na Yi:1.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China. ; Jihua Ran:1.Clinical Laboratory Diagnostic Center, General Hospital of Xinjiang Military Region, Urumqi, China. ; Yan Chen:1.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi,

    期刊:New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network

    DOI:10.21037/tcr-23-141

    影响因子 :0.9

    引用产品: KTC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  NY-OPI3-1 细胞 ,  KTC-1细胞专用培养基 ,  B-CPAP [BC-PAP; BCPAP]细胞专用培养基 ,  人甲状腺滤泡上皮细胞

  • The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo (2001-01-20)

    作者:Fangqin Yu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Lele Zhang:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Runsheng Ma:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Chenguang Liu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Qingduan Wang:1.Zhengzhou University, Academy of Medical and Pharmaceutical Sciences, Henan Key Laboratory for Pharmacology of Liver Diseases, Zhengzhou, China. ; Detao Yin:1.Department of Thyroid Surgery, The First Aff

    期刊:The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo

    DOI:10.1155/2021/8869323

    影响因子 :2.7

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  SW579 [SW 579; SW-579] 细胞 ,  FTC-133 细胞

  • Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells (2003-00-20)

    作者:Tao Zhang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Xuan Ren: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Zhuan** Wang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Yahong Liu: 1.Department of Pediatrics,Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Hongjuan Wang: 1.Department of Respiratory, Gansu Provincial People’s Hospital, 204 Donggang West Road, Lanzhou, 730000, Gansu, China;

    期刊:Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells

    DOI:10.1007/s13273-020-00073-x

    影响因子 :1.7

    引用产品: 人甲状腺滤泡上皮细胞 ,  TPC-1 细胞 ,  FTC-133 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  NCI-H1563 细胞 ,  人甲状腺癌组织源细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号